Our study used a human liver disease tissue microarray, cellular experiments, and animal models to demonstrate that HMGCS2 controls the proliferation and migration abilities of liver cancer cells by regulating the apoptosis, c-Myc/cyclin D1, and EMT signaling pathways and acts in a ketogenesis enzyme-dependent manner. Here, HMGCS2 is linked to liver cancer.